1. Home
  2. ICUCW vs ECCC Comparison

ICUCW vs ECCC Comparison

Compare ICUCW & ECCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SeaStar Medical Holding Corporation Warrant

ICUCW

SeaStar Medical Holding Corporation Warrant

HOLD

Current Price

$0.01

Market Cap

0.0

Sector

Health Care

ML Signal

HOLD

ECCC

Eagle Point Credit Company Inc. 6.50% Series C Term Preferred Stock due 2031

N/A

Current Price

$23.88

Market Cap

0.0

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
ICUCW
ECCC
Founded
N/A
N/A
Country
United States
United States
Employees
18
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
N/A
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
ICUCW
ECCC
Price
$0.01
$23.88
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
N/A
N/A
Earning Date
N/A
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
N/A
N/A
52 Week High
N/A
N/A

Technical Indicators

Market Signals
Indicator
ICUCW
ECCC
Relative Strength Index (RSI) 35.52 63.64
Support Level $0.01 $23.55
Resistance Level $0.01 $23.90
Average True Range (ATR) 0.00 0.15
MACD 0.00 0.04
Stochastic Oscillator 15.85 96.36

Price Performance

Historical Comparison
ICUCW
ECCC

About ICUCW SeaStar Medical Holding Corporation Warrant

SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.

About ECCC Eagle Point Credit Company Inc. 6.50% Series C Term Preferred Stock due 2031

Eagle Point Credit Co Inc. is an externally managed, non-diversified closed-end management investment company. Its primary investment objective is to generate high current income, with a secondary objective of capital appreciation. The Company seeks to achieve its investment objectives by investing in equity and junior debt tranches of collateralized loan obligations ("CLOs") collateralized by a portfolio consisting of below-investment-grade U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors. The Company intends to operate so as to qualify to be taxed as a regulated investment company.

Share on Social Networks: